Home
News
Videos
Podcasts
Menu
Акционерное общество "ТВ БРИКС"
tvbrics@tvbrics.com
Рубцов переулок, д.13, Москва, 105082, RU
+74996425304
Currencies:
RUB/USD 0,0119
0,0000
BRL/USD 0,1942
0,0001
INR/USD 0,0104
0,0000
CNY/USD 0,1487
0,0001
ZAR/USD 0,0627
0,0003
IDR/USD 0,0001
0,0000
SPACE FOR MEDIA DIPLOMACY
10:00 Documentary film «Worthy of Applause: New Roles for BRICS+ Actors»
10:00 Documentary film «Worthy of Applause: New Roles for BRICS+ Actors»
Now 16+
10:00

Documentary film «Worthy of Applause: New Roles for BRICS+ Actors»

It is indicated Moscow time in the programme. Please take into account the time difference with your time zone.
10:30 «City of stories»
Next
10:30

«City of stories»

16+
11:00

«BRICSreport»

16+
11:15

«BRICSterview»

16+
Menu
Broadcast Documentary film «Worthy of Applause: New Roles for BRICS+ Actors»
RUB/USD
0,0119
0,0000
BRL/USD
0,1942
0,0001
INR/USD
0,0104
0,0000
CNY/USD
0,1487
0,0001
ZAR/USD
0,0627
0,0003
IDR/USD
0,0001
0,0000
TV BRICS Apps
China expands medical insurance to bolster rare disease treatment access

China has strengthened its national network for rare disease diagnosis and treatment

China's commitment to improving healthcare for rare disease patients has taken a significant leap forward, with the latest update to the national medical insurance catalogue now covering 13 additional treatments for rare conditions. This is reported by Xinhua News Agency, a partner of TV BRICS.

This brings the total number of such therapies under insurance coverage to over 90, according to the National Healthcare Security Administration (NHSA).

The revised catalogue, developed in collaboration with various governmental bodies, includes medicines targeting conditions such as hypertrophic cardiomyopathy, refractory epilepsy, and paroxysmal nocturnal haemoglobinuria. These updates aim to address the unique challenges of rare diseases, including low prevalence, limited patient numbers, and the high costs of research and development.

This initiative is part of broader efforts to make life-saving treatments more accessible and affordable for patients nationwide.

In addition to increasing insurance coverage, China has strengthened its national network for rare disease diagnosis and treatment. As of October 2024, more than 400 medical institutions have joined the network, which features referral systems, telemedicine services, and comprehensive coverage across all provincial-level regions.

These initiatives ensure better access to specialised care and foster the development of rare disease research and treatment pathways.

Photo: iStock